Results for:

Filter by:


CureTalks@Penn interviews Penn Medicine physicians about their cutting edge research and clinical trials. Our goal is to inform patients, care-givers, patient advocates and other physicians about research that occurs at Penn Medicine.

View More

22 "Lung Disease" clinical trials found.

  • Responsive image

    Determination of B-cell responsiveness to the incretin hormones GLP-1 and GIP in Cystic Fibrosis (PRIME)

    The mechanisms underlying cystic fibrosis related diabetes (CFRD) pathophysiology must be better defined if care for people with CFRD is ...

  • Responsive image

    An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension

    This is a Phase 3a, extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension ...

    profile picture Harold Palevsky Md

  • Responsive image

    Pilot study for functional and structural MR Imaging of Endobroncial valve recipients using hyperpoloarized XENON-129

    We propose to use gas Magnetic Resonance Imaging (MRI) using the inhaled contrast agent, hyperpolarized (HP) xenon-129, to study the ...

    profile picture Maurizio Cereda

  • Responsive image

    Attain StarFix Model 4195 LV Lead Extraction Study

    The purpose of this study is to characterize the removability of the Attain StarFix®Model 4195 Left Ventricular (LV) Lead ...

    profile picture Robert Schaller

  • Responsive image

    Intraoperative molecular imaging of pulmonary nodules by BY SGM-101

    profile picture Sunil Singhal Md

  • Responsive image

  • Responsive image

    Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer

    Surgery is the best treatment for patients with Stage I or II lung cancer; however, nearly 60% of patients have ...

    profile picture Sunil Singhal Md profile picture Charuhas Deshpande profile picture Lydia Frenzel Sulyok

  • “The Shift Worker’s Microbiome”

    We are looking for healthy males, age 40-59 years old, non-smoking un-medicated who work the "shift-work" schedule (>3 shifts per ...

    profile picture Lavenia M Banas, Rn

  • UPCC 09517: Phase II study of Pembrolizumab and Itacitinib (INCB039110) for First Line Treatment of Metastatic Non-Small Cell Lung Cancer ...

    The main purpose of this study is to examine the efficacy of adding itacitinib (also known as INCB039110) to pembrolizumab ...

    profile picture Joshua Bauml

  • UPCC 06518: A Phase 2 Precision Oncology Study of Biomarker-Directed Pembrolizumab-Based Combination Therapy for Advanced Non-Small Cell Lung Cancer

    To evaluate the clinical activity (as assessed by objective response rate [ORR]) pembrolizumab (MK-3475) in combination with MK-4280 or lenvatinib ...

    profile picture Charu Aggarwal

Showing - of trials